CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 217 SEK 1.17% Market Closed
Market Cap: 5.2B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CellaVision AB
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Total Liabilities & Equity
kr983.8m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
18%
Elekta AB (publ)
STO:EKTA B
Total Liabilities & Equity
kr31.4B
CAGR 3-Years
8%
CAGR 5-Years
5%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Total Liabilities & Equity
kr4.8B
CAGR 3-Years
8%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Total Liabilities & Equity
kr53.6B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Liabilities & Equity
kr15.4B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Total Liabilities & Equity
kr1B
CAGR 3-Years
49%
CAGR 5-Years
46%
CAGR 10-Years
34%
No Stocks Found

CellaVision AB
Glance View

Market Cap
5.2B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
265.65 SEK
Undervaluation 18%
Intrinsic Value
Price

See Also

What is CellaVision AB's Total Liabilities & Equity?
Total Liabilities & Equity
983.8m SEK

Based on the financial report for Sep 30, 2024, CellaVision AB's Total Liabilities & Equity amounts to 983.8m SEK.

What is CellaVision AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
18%

Over the last year, the Total Liabilities & Equity growth was 10%. The average annual Total Liabilities & Equity growth rates for CellaVision AB have been 10% over the past three years , 18% over the past five years , and 18% over the past ten years .

Back to Top